Rezolute (RZLT) Equity Average (2011 - 2026)
Rezolute's (RZLT) quarterly Equity Average came in at $122.4 million in Q1 2026, up 34.41% year-on-year from $91.1 million in Q1 2025, and down 11.02% quarter-over-quarter from $137.6 million in Q4 2025.
Rezolute (RZLT) Equity Average (2011 - 2026) Analysis & Trends
Rezolute has disclosed Equity Average across 16 years of filings, most recently posting $122.4 million for Q1 2026.
- Equity Average for Q1 2026 came in at $122.4 million, up 34.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $122.4 million (up 34.41% YoY), and the FY2025 annual result was $141.6 million, up 19.38% from the prior year.
- Equity Average came in at $122.4 million for Q1 2026 at Rezolute, down from $137.6 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $154.6 million in Q3 2025 to a low of $57.1 million in Q1 2022.
- The 5-year median for Equity Average is $117.2 million (2024), against an average of $114.6 million.
- Across the five-year window, Equity Average soared 534.86% in 2022 and plunged 39.46% in 2024, its largest moves.
- Rezolute's Equity Average stood at $147.2 million in 2022, then plunged by 33.65% to $97.6 million in 2023, then gained by 9.08% to $106.5 million in 2024, then rose by 29.17% to $137.6 million in 2025, then fell by 11.02% to $122.4 million in 2026.
- The last three Equity Average figures came in at $122.4 million (Q1 2026), $137.6 million (Q4 2025), and $154.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 122.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.42 Mn |
| Dec 31, 2025 | 137.58 Mn |
| Sep 30, 2025 | 154.65 Mn |
| Jun 30, 2025 | 122.35 Mn |
| Mar 31, 2025 | 91.08 Mn |
| Dec 31, 2024 | 106.52 Mn |
| Sep 30, 2024 | 117.22 Mn |
| Jun 30, 2024 | 95.93 Mn |
| Mar 31, 2024 | 81.29 Mn |
| Dec 31, 2023 | 97.65 Mn |
| Sep 30, 2023 | 109.87 Mn |
| Jun 30, 2023 | 121.74 Mn |
| Mar 31, 2023 | 134.29 Mn |
| Dec 31, 2022 | 147.18 Mn |
| Sep 30, 2022 | 151.28 Mn |
| Jun 30, 2022 | 100.69 Mn |
| Mar 31, 2022 | 57.09 Mn |
| Dec 31, 2021 | 41.91 Mn |
| Sep 30, 2021 | 23.83 Mn |
| Jun 30, 2021 | 27.62 Mn |